Catalyst Wire Dossier Catalyst Wire Dossier

V211-009 vaccine

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V211-009 vaccine, covering 2010-06-10 to 2010-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009) [Phase 3]

See pricing